Charlottenlund, Denmark

Matthias Thórólfsson

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignees: Innate Pharma S.a.s., Novo Nordisk A/s, University of Genoa. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthias Thórólfsson. Retrieved from https://idiyas.com/inventor/matthias-thórólfsson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matthias Thorolfsson: Innovator in the Pharmaceutical Industry

Introduction

Matthias Thorolfsson is a notable inventor based in Charlottenlund, Denmark. He has made significant contributions to the pharmaceutical industry through his work with leading companies. Although he currently holds no patents, his experience and expertise in the field are noteworthy.

Latest Patents

Matthias Thorolfsson has not registered any patents to date. His focus has been on research and development within the pharmaceutical sector rather than patenting inventions.

Career Highlights

Throughout his career, Matthias has worked with prominent companies such as Novo Nordisk A/S and Innate Pharma. His roles in these organizations have allowed him to contribute to innovative projects and advancements in healthcare.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Matthias Thorolfsson is an influential figure in the pharmaceutical industry, known for his work with major companies. His contributions, although not reflected in patents, demonstrate his commitment to innovation and advancement in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…